Nomura Micro Science (野村マイクロ・サイエンス, 6254.T) kept its full-year operating profit guide at ¥16.0B. First-half operating profit was ¥1.1B.
That leaves ¥14.9B, 93% of the year, for the second half (my calc).
First half, April to September:
- Sales ¥24.1B, down 4%
- Operating profit ¥1.1B, down 61%, with an ordinary loss of ¥0.16B
- Orders ¥50.8B, up 227% (Q1 ¥38.9B, Q2 ¥11.9B, my calc)
- Full-year guide unchanged: sales ¥97.0B, operating profit ¥16.0B
The company builds ultra-pure water (UPW) systems for semiconductor fabs.
It attributes the first-half sales decline to large US and Japan projects rolling off. Revenue from large new orders in Japan is expected from the second half onward.
The number that explains the second half is the order plan. In its Q1 supplementary materials in August, the company set a full-year order plan of ¥164.8B. The US accounts for ¥92.6B, or 56%. First-half orders of ¥50.8B cover 31% of the plan.
Korea was the weak spot. Korea segment sales rose 3% to ¥2.1B, but the segment posted an operating loss of ¥0.74B against a ¥0.09B profit a year earlier. The company cites higher costs on some large water treatment systems.
Taiwan went the other way: sales up 277% to ¥4.8B, with ¥0.48B of operating profit.
My read: the number to watch here is not margin but order timing. More than half of this year's order plan sits in one region, the US.
What would prove me wrong: the supplementary materials and the Nov 18 briefing will show when US orders land in the second half, and Q3 results in February will show how far nine-month operating profit sits from the ¥16.0B guide.
Source: Nomura Micro Science Q2 FY3/27 tanshin (Nov 13), Q1 supplementary materials (Aug 7). Second-half profit, Q2 orders and plan ratios are my arithmetic.
显示更多